.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,136,347

« Back to Dashboard

Summary for Patent: 6,136,347

Title: Flavor-masked pharmaceutical compositions
Abstract:The invention relates to flavor-masked pharmaceutical compositions for oral administration, their preparation and their use as medicaments. The new pharmaceutical preparations according to the invention make it possible to administer pharmaceutical active substances having very unpleasant organoleptic properties such as, for example, very bad taste, even in liquid form.
Inventor(s): Pollinger; Norbert (Odenthal, DE), Michaelis; Johannes (Cologne, DE), Benke; Klaus (Kyoto, JP), Rupp; Roland (Leichlingen, DE), Bucheler; Manfred (Overath, DE)
Assignee: Bayer Aktiengesellschaft (Leverkusen, DE)
Application Number:08/653,535
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form; Formulation; Use;
Patent Metrics:
Source: PatentQuant.com
Field: Not categorized
Back Citations: 19th percentile
Forward Citations: 5th percentile
Patent PDF download available with subscription

No matches for this query

Foreign Priority and PCT Information for Patent: 6,136,347

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany42 00 821Jan 15, 1992

International Patent Family for Patent: 6,136,347

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria186212<disabled in preview>
Australia3113893<disabled in preview>
Australia670763<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc